Published in Antiviral Res on August 01, 1982
Synthesis and secretion of interferon by murine fibroblasts in response to intracellular Listeria monocytogenes. Infect Immun (1986) 4.14
Behavior of a cloned murine interferon alpha/beta receptor expressed in homospecific or heterospecific background. Proc Natl Acad Sci U S A (1992) 1.28
Interferon induces pulmonary cysts in A2G mice. Proc Natl Acad Sci U S A (1984) 0.82
Inducible gene targeting in mice. Science (1995) 21.22
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell (1996) 10.49
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity (1999) 8.33
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82
VEGF is required for growth and survival in neonatal mice. Development (1999) 6.16
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J (2001) 5.29
Induction of tumor necrosis factor alpha expression in human T lymphocytes following ionizing gamma irradiation. J Interferon Cytokine Res (1996) 4.88
The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol (1997) 4.76
Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science (1995) 4.59
Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol (1995) 4.16
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med (1993) 3.48
Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med (1976) 3.28
Functional analysis of T lymphocyte subsets in antiviral host defense. J Immunol (1987) 3.11
A method for the large scale production of potent interferon preparations. Proc Soc Exp Biol Med (1974) 3.01
Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev (1995) 2.97
Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med (1995) 2.80
Structure and expression of a cloned cDNA for mouse interferon-beta. J Biol Chem (1983) 2.61
The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med (1998) 2.55
The role of antibody concentration and avidity in antiviral protection. Science (1997) 2.45
Activation of latent Epstein-Barr virus by antibody to human IgM. Nature (1978) 2.33
Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J (1994) 2.27
Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J Exp Med (1995) 2.19
The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J (1994) 2.19
Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J Exp Med (1995) 2.17
Characterization of rapidly labeled ribonucleic acid of animal cells in culture. Biochim Biophys Acta (1965) 2.15
Antitumor effects of interferon. Biochim Biophys Acta (1978) 2.04
Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med (1994) 1.95
High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Nature (1980) 1.94
Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science (1995) 1.90
Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int Immunol (1996) 1.83
Purification of mouse interferon by sequential affinity chromatography on poly(U)--and antibody--agarose columns. Nature (1978) 1.81
Fusion of erythrocytes by Sendai virus studied by immuno-freeze-etching. J Virol (1973) 1.71
Lethality of interferon preparations for newborn mice. Nature (1975) 1.65
CD40 ligand has potent antiviral activity. Nat Med (1995) 1.64
Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J Virol (1995) 1.60
Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens. J Exp Med (1986) 1.55
Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc Natl Acad Sci U S A (1997) 1.52
A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells. Cell (1994) 1.49
Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc Natl Acad Sci U S A (1977) 1.49
Role of interferon-gamma in interleukin 12-induced pathology in mice. Am J Pathol (1995) 1.49
Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc Natl Acad Sci U S A (1993) 1.45
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Mult Scler (2008) 1.42
Identification of the cell multiplication inhibitory factors in interferon preparations as interferons. Nature (1976) 1.41
Interferon receptors. Interferon (1983) 1.39
Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci U S A (1987) 1.36
Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol (1996) 1.32
High affinity binding of 125I-Labeled mouse interferon to a specific cell surface receptor. II. Analysis of binding properties. Virology (1981) 1.29
Electrophoretically pure mouse interferon exerts multiple biologic effects. Proc Natl Acad Sci U S A (1979) 1.28
An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer. J Interferon Res (1980) 1.28
Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J Exp Med (2000) 1.26
IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J Immunol (1994) 1.26
Development of antimalaria immunity in mice lacking IFN-gamma receptor. J Immunol (1995) 1.25
Binding of 125I-labelled human alpha interferon to human lymphoid cells. Int J Cancer (1981) 1.25
Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. Am J Pathol (1981) 1.24
Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J Biol Chem (1998) 1.23
Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors. J Exp Med (1983) 1.22
Quantitation of neutralization of interferon by antibody. Methods Enzymol (1986) 1.22
The relationship between the interferon alpha response and viral burden in primary SIV infection. AIDS Res Hum Retroviruses (1996) 1.21
Similarity of idiotypic determinants of T-and B-lymphocyte receptors for alloantigens. Immunol Rev (1977) 1.21
Multiple roles of mouse Numb in tuning developmental cell fates. Curr Biol (2001) 1.20
125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data. J Gen Virol (1985) 1.20
Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice. J Gen Virol (1975) 1.19
Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J Immunol (1996) 1.18
Antigenicity of mouse interferons: distinct antigenicity of the two L cell interferon species. Virology (1980) 1.15
Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons. J Gen Virol (1987) 1.14
High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect Immun (1982) 1.14
Biological activities and receptor binding of two human recombinant interferons and their hybrids. J Gen Virol (1986) 1.14
Various human interferon alpha subclasses cross-react with common receptors: their binding affinities correlate with their specific biological activities. Virology (1984) 1.14
Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene (2006) 1.13
Specific high-affinity binding of 125I-labeled mouse interferon to interfevon resistant embryonal carcinoma cells in vitro. Virology (1981) 1.10
Evolution of interferon genes. Interferon (1985) 1.09
Interferon suppresses the transition of quiescent 3T3 cells to a growing state. Nature (1977) 1.08
Interferon enhances the expression of Fc gamma receptors. J Immunol (1980) 1.08
Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages. J Virol (1985) 1.06
Purification of human gamma interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human gamma interferon. J Exp Med (1987) 1.06
Interferon-induced disease in mice and rats. Ann N Y Acad Sci (1980) 1.06
Inhibition by interferon of thymidine uptake in chemostat cultures of L1210 cells. Intervirology (1978) 1.04
Neutralization of interferon by antibody: appraisals of methods of determining and expressing the neutralization titer. J Interferon Res (1984) 1.00
The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon. J Virol (1995) 0.99
Isolation of Daudi cells with reduced sensitivity to interferon. I. Characterization. J Gen Virol (1983) 0.99
Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics. J Interferon Cytokine Res (1999) 0.99
Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virus. J Gen Virol (1987) 0.98
The gene for the ligand binding chain of the human interferon gamma receptor. Immunogenetics (1997) 0.97
The nature of neutralization reaction between effector protein and monoclonal antibody: a quantitative study of neutralization characteristics of anti-interferon antibodies. Immunology (1985) 0.97
Functional characterization of a hybrid human-mouse interferon gamma receptor: evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer. Proc Natl Acad Sci U S A (1992) 0.97
A negative regulatory region in the intracellular domain of the human interferon-alpha receptor. J Biol Chem (1996) 0.96
Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes. Cell Immunol (1982) 0.96
Marked enhancement of interferon production in 5-bromodeoxyuridine treated human lymphoblastoid cells. Nature (1977) 0.96
Rapid increase of the human IFN-gamma receptor phosphorylation in response to human IFN-gamma and phorbol myristate acetate. Involvement of different serine/threonine kinases. J Immunol (1990) 0.96
Synthesis and secretion of biologically active mouse interferon-beta using a Bacillus subtilis alpha-amylase secretion vector. Gene (1985) 0.96